Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5769-5779

  Ashwanikumar, N ^a   Kumar, Nisha Asok ^a   Asha Nair, S ^a   Vinod Kumar, G S ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

Author keywords

5 FU; Colon cancer; Methacrylic polymer; Nanogel

Indexed keywords

FLUOROURACIL; METHACRYLIC ACID; PHOSPHATE BUFFERED SALINE;

ARTICLE; ATOMIC FORCE MICROSCOPY; CANCER CELL CULTURE; CELL ASSAY; CELL PROLIFERATION; CELL TRANSPORT; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STRUCTURE; EVAPORATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; INFRARED SPECTROSCOPY; MICROEMULSION; NANOENCAPSULATION; NANOPHARMACEUTICS; PARTICLE SIZE; PH MEASUREMENT; PROTON NUCLEAR MAGNETIC RESONANCE; S PHASE CELL CYCLE CHECKPOINT; SUSTAINED DRUG RELEASE; TIMED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; DELAYED-ACTION PREPARATIONS; FLUOROURACIL; GELS; HUMANS; HYDROGEN-ION CONCENTRATION; METHACRYLATES; NANOCAPSULES; TREATMENT OUTCOME;

EID: 84870310796     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S31201     Document Type: Article

References (28)

1. Van Cutsem E, Peeters M, Verslype C, Filez L, Haustermans K, Janssens J. The medical treatment of colorectal cancer: actual status and new developments. Hepatogastroenterology. 1999;46(26):709-716.
2. Fata F, Ron IG, Kemeny N, O'Reilly E, Klimstra D, Kelsen DP. 5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma. Cancer. 1999;86(7):1129-1134.
3. Di Paolo A, Danesi R, Falcone A, etal. Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients. Ann Oncol. 2001;12(9):1301-1306.
4. Lamprecht A, Yamamoto H, Takeuchi H, Kawashima Y. Microsphere design for the colonic delivery of 5-fluorouracil. J Control Release. 2003;90(3):313-322.
5. Kim IS, Kim SH, Cho CS. Drug release from pH-sensitive interpenetrating polymer networks hydrogel based on poly (ethylene glycol) macromer and poly (acrylic acid) prepared by UV cured method. Arch Pharm Res. 1996;19(1):18-22.
6. Gander B, Gurny R, Doelker E, Peppas NA. Effect of polymeric network structure on drug release from cross-linked poly(vinyl alcohol) micromatrices. Pharm Res. 1989;6(7):578-584.
7. Colombo P, Santi P, Bettini R, Brazel CS. Drug release from swelling-controlled systems. In: Wise DL, editor. Handbook of Pharmaceutical Controlled Release Technology. New York, NY: Marcel Dekker; 2000: 183-209.
8. Kim B, La Flamme K, Peppas NA. Dynamic swelling behavior of pH-sensitive anionic hydrogels uses for protein delivery. J Appl Polym Sci. 2003;89(6):1606-1613.
9. Wang K, Xu X, Liu TT, etal. Synthesis and characterization of biodegradable pH-sensitive hydrogel based on poly(ε-caprolactone), methacrylic acid, and Pluronic (L35). Carbohydr Polym. 2010;79(3): 755-761.
10. De Groot CJ, Van Luyn MJ, Van Dijk-Wolthuis WN, etal. In vitro biocompatibility of biodegradable dextran-based hydrogels tested with human fibroblasts. Biomaterials. 2001;22(11):1197-1203.
11. Otto DP, Vosloo HC, Liebenberg W, de Villiers MM. Development of microporous drug releasing film cast from artificial nanosized latexes of poly(styrene-co-methyl methacrylate) or poly(styrene-co-ethyl methacrylate). Eur J Pharm Biopharm. 2008;69(3):1121-1134.
12. Zhao Y, Yokoi H, Tanaka M, Kinoshita T, Tan T. Self-assembled pH-responsive hydrogels composed of the RATEA16 peptide. Biomacromolecules. 2008;9(6):1511-1518.
13. Fallingborg J, Christensen L, Ingeman-Nielsen M, Jacobsen B, Abildgaard K, Rasmussen HH. pH-Profile and regional transit times of the normal gut measured by a radiotelemetry device. Aliment Pharmacol Ther. 1989;3(6):605-613.
14. Yang L, Chu JS, Fix JA. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm. 2002;235(1-2):1-15.
15. Penzel E, Rieger J, Schneider HA. The glass transition temperature of random copolymers: 1. Experimental data and the Gordon-Taylor equation. Polymer. 1997;38(2):325-337.
16. Simbulan-Rosenthal CM, Rosenthal DS, Iyer S, Boulares AH, Smulson ME. Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis. J Biol Chem. 1998;273(22):13703-13712.
17. Boulares AH, Yakovlev AG, Ivanova V, etal. Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J Biol Chem. 1998;274(33):22932-22940.
18. Guo X, Goessl E, Jin G, etal. Cell cycle perturbation and acquired 5-fluorouracil chemoresistance. Anticancer Res. 2008;28(1A):9-14.
19. Miquelard-Garnier G, Demoures S, Creton C, Hourdet D. Synthesis and rheological behavior of new hydrophobically modified hydrogels with tunable properties. Macromolecules. 2006;39(23):8128-8139.
20. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release. 2001;70(1-2):1-20.
21. Nair KL, Jagadeeshan S, Nair SA, Kumar GS. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Int J Nanomedicine. 2011;6:1685-1697.
22. Nagane M, Pan G, Weddle JJ, Dixit VM, Cavenee WK, Huang HJ. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res. 2000;60(4):847-853.
23. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 1993;74(6): 957-967.
24. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411(6835):342-348.
25. Pinto AC, Moreira JN, Simoes S. Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent manner. Cancer Chemother Pharmacol. 2009;64(3):445-454.
26. Di Salvatore M, Orlandi A, Bagalà C, etal. Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line. Cell Prolif. 2011;44(2):139-146.
27. Parveen S, Mitra M, Krishnakumar S, Sahoo SK. Enhanced antiproliferative activity of carboplatin-loaded chitosan-alginate nanoparticles in a retinoblastoma cell line. Acta Biomater. 2010;6(8): 3120-3131.
28. Yoshikawa R, Kusunoki M, Yanagi H, etal. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res. 2001;61(3):1029-1037.